Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
lisinopril dihydrate, Quantity: 21.78 mg (Equivalent: lisinopril, Qty 20 mg)
AVALLON PHARMACEUTICALS PTY LTD
Lisinopril dihydrate
Tablet
Excipient Ingredients: croscarmellose sodium; mannitol; maize starch; magnesium stearate; iron oxide red; calcium hydrogen phosphate dihydrate
Oral
30
(S4) Prescription Only Medicine
1.Hypertension: NOUMED LISINOPRIL is indicated for the treatment of hypertension. It may be used alone or concomitantly with other classes of antihypertensive agents. Sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. 2. Congestive heart failure: NOUMED LISINOPRIL is also indicated for the treatment of heart failure. In such patients, it is recommended that lisinopril be administered together with a diuretic. 3. Acute myocardial infarction: NOUMED LISINOPRIL is indicated for the treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100mmHg. Lisinopril may be initiated within 24 hours of an acute myocardial infarction.
Visual Identification: Round, convex and a score notch on one side. The tablets are uniformly red, mottled, the surface must be smooth.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 60 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-06-14